Author

Lauren Masaki

Institution: Unity Biotechnology (United States)

Observed institutions: Unity Biotechnology (United States), Stanford Medicine, Stanford University

OpenAlex ID: A5000970109

Therapeutic targeting of cellular senescence in diabetic macular edema: preclinical and phase 1 trial results

2024 · Sergio Crespo-Garcia, Frédérik Fournier, et al. · Nature Medicine · 101

Tetrahydrobiopterin as a Treatment for Autism Spectrum Disorders: A Double-Blind, Placebo-Controlled Trial

2013 · Cheryl Klaiman, Lynne Huffman, et al. · Journal of Child and Adolescent Psychopharmacology · 63

Safety and Efficacy of Senolytic UBX1325 in Diabetic Macular Edema

2025 · Sharon Klier, Jamie Dananberg, et al. · NEJM Evidence · 23

Works count: 3

Citation count: 187

H-index: 3

I10-index: 3